Pharmacology/Pharmaceutical Industry
Meta-analysis: Effectiveness of honey for symptomatic relief in upper respiratory tract infections
20 Aug, 2020 | 09:15h | UTCCommentaries: Honey may be better at treating coughs and colds than over-the-counter medicines – CNN AND Honey found to be a better treatment for upper respiratory tract infections than traditional remedies – MedicalXpress AND Honey better treatment for coughs and colds than antibiotics, study claims – The Guardian
[Abstract Only] Observational study: Atypical femur fracture risk vs. fragility fracture prevention with bisphosphonates
20 Aug, 2020 | 09:12h | UTC
Perspective: What the immune response to the coronavirus says about the prospects for a vaccine
19 Aug, 2020 | 09:39h | UTCWhat the immune response to the coronavirus says about the prospects for a vaccine – Nature
Meta-analysis: Use of inhibitors of the renin‐angiotensin system in hypertensive patients and COVID‐19 severity
19 Aug, 2020 | 09:35h | UTC
Study: 75% of Patients with dementia using psychotropic and opioid medications not made for the disease
19 Aug, 2020 | 09:27h | UTCPrevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US – JAMA (free for a limited period)
Commentaries: These Drugs Carry Risks and May Not Help, But Many Dementia Patients Get Them Anyway – Michigan Medicine AND 3 in 4 Elders with Dementia Fill Prescriptions for Psychotropics or Opioids – NEJM Journal Watch
Commentary from the author (Thread – click for more)
We wrote a new thing out in @JAMA_current examining the mind-bogglingly high rate of psychotropic and opioid use among older adults with #dementia in the community:https://t.co/4FRGQcp70B pic.twitter.com/hB3KDSnXMg
— Donovan Maust (@dtmaust) August 18, 2020
Prior routine use of NSAIDs and outcomes in hospitalized patients with COVID-19
18 Aug, 2020 | 07:36h | UTCCommentary: Study finds ibuprofen does not increase risk of death from COVID-19 – University of Aberdeen
[Abstract Only] Randomized trial: Effect of sustained-release morphine for refractory breathlessness in COPD
18 Aug, 2020 | 07:25h | UTC
Commentary on Twitter
Sustained-Release Morphine improves quality of life in patients with #COPD and refractory #breathlessness https://t.co/whXcWPlKiv via @JAMAInternalMed part of @JAMANetwork #pallipulm
— Daisy Janssen (@DJAJanssen) August 17, 2020
ACP/AAFP Guideline: Nonpharmacologic and pharmacologic management of acute pain from non–low back, musculoskeletal injuries in adults
18 Aug, 2020 | 07:30h | UTCNews Release: ACP, AAFP release new guideline for treatment of non-low back pain – American College of Physicians
Commentary: ACP, AAFP issue joint guideline on non-low back pain from musculoskeletal injuries in adults – ACP Internist
Randomized trial: Imipenem/Cilastatin/Relebactam vs. Piperacillin/Tazobactam in adults with hospital-acquired or ventilator-associated bacterial pneumonia
16 Aug, 2020 | 22:12h | UTC
Randomized trial: Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19
14 Aug, 2020 | 01:53h | UTCRelated Study: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report – New England Journal of Medicine
Commentary on Twitter
Metcovid Double Blind PH. 2
RCT ??~ 400 pts #CID
Methylprednisolon 0.5mg/kg twice daily x5d #COVID19 Hospitalized pts #COVID19 did not reduce 28d mortality V placebo
Is it Right Drug, Dose, Duration
High dose vs RECOVERY
DEX less mineralocorticoid
5 v 10 https://t.co/EBIRWYouSQ pic.twitter.com/OzGJkqjkrJ— Antibiotic Steward? Bassam Ghanem (@ABsteward) August 13, 2020
These Covid-19 vaccine candidates could change the way we make vaccines — if they work
14 Aug, 2020 | 01:43h | UTCThese Covid-19 vaccine candidates could change the way we make vaccines — if they work – Vox
Effect of an inactivated vaccine against SARS-CoV-2 on safety and immunogenicity outcomes
14 Aug, 2020 | 01:44h | UTC
Commentary on Twitter
Inactivated #COVID19 #vaccine had a low rate of adverse reactions and demonstrated immunogenicity, but longer-term assessment of safety and efficacy will require phase 3 trials https://t.co/atmhXFFHSw
— JAMA (@JAMA_current) August 13, 2020
Systematic review: The use of erythropoietin plus iron to correct anemia before surgery to reduce the risk of blood transfusion
14 Aug, 2020 | 01:04h | UTC
Randomized trial: AVIFAVIR for Treatment of Patients with Moderate COVID-19
13 Aug, 2020 | 00:28h | UTC
Commentary on Twitter
NEW ?? #CID @IDSAInfo
AVIFAVIR(favipiravir) for Treatment of Patients with Moderate #COVID19 : Interim Results of a Phase II/III Multicenter Randomized Clinical Trial #IDTwitter https://t.co/PwUcCWu5KQ pic.twitter.com/6N6lxHUu9K— Antibiotic Steward? Bassam Ghanem (@ABsteward) August 8, 2020
Russia’s rapid COVID-19 vaccine approval draws intense criticism from some – and offers to collaborate from others
13 Aug, 2020 | 00:25h | UTC
[Abstract Only] Randomized trial: Effect of aspirin on cancer incidence and mortality in older adults
12 Aug, 2020 | 23:59h | UTCCommentary: Aspirin may accelerate progression of advanced cancers in older adults – Massachusetts General Hospital
Randomized trial: No benefit from combination therapy of vitamin C and thiamine for septic shock
13 Aug, 2020 | 00:01h | UTC
Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?
12 Aug, 2020 | 02:38h | UTCAntibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit? – Nature
Related: Antibody drugs could be one of the best weapons against Covid-19. But will they matter? – STAT AND Designer antibodies could battle COVID-19 before vaccines arrive – Science
Russia has approved ‘world first’ Covid-19 vaccine. But questions over its safety remain
12 Aug, 2020 | 02:28h | UTCSee also: Russia has launched the world’s first COVID-19 vaccine: Here’s all you need to know – Firstpost AND Coronavirus: Putin says vaccine has been approved for use – BBC AND Russia Approves Coronavirus Vaccine Before Completing Tests – The New York Times AND The Russian Vaccine – Science Translational Medicine AND Russia claims first coronavirus vaccine as global cases top 20 million – MedicalXpress
Opinion – “Covid-19 drug research is a big huge mess”
11 Aug, 2020 | 10:25h | UTCCovid-19 Drug Research Is a Big Huge Mess – Wired
[Preprint] Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: Report of the randomized, double-blind, and placebo-controlled phase 2 clinical trial
11 Aug, 2020 | 10:19h | UTC
Commentary on Twitter
1st human data for an inactivated Covid-19 vaccine is out! Coronavac (by Sinovac) phase 2 data, for 480 people + 120 on placebo. Antibodies but not T-cells reported: 97% seroconversion 28 days after 2nd injection, but less for people over 50 … https://t.co/emJG9DQrkh 1/2 pic.twitter.com/bi72NlmkSH
— Hilda Bastian (@hildabast) August 11, 2020
[Abstract Only] Randomized trial: Prevention of benign paroxysmal positional vertigo with Vit D supplementation
10 Aug, 2020 | 01:49h | UTCCommentary: Fewer Vertigo Recurrences with Vitamin D, Calcium – Physician’s Weekly
[Abstract Only] Case-control study: Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects
10 Aug, 2020 | 01:51h | UTC
AAP Clinical Report: Long-acting reversible contraception: specific issues for adolescents
7 Aug, 2020 | 03:10h | UTCLong-Acting Reversible Contraception: Specific Issues for Adolescents – Pediatrics
Commentary: Teens need easy access to condoms and long-acting reversible contraception, say pediatricians – CNN
[Abstract Only] Randomized trial: Continuing vs. tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis
6 Aug, 2020 | 02:53h | UTCCommentary: Reducing corticosteroid use in rheumatoid arthritis – Charité – Universitätsmedizin Berlin
Commentary on Twitter
NEW Research—Continuing vs tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial https://t.co/gtR7xmZlGS pic.twitter.com/UO1EqItU66
— The Lancet (@TheLancet) July 28, 2020